Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04034992 · ClinicalTrials.gov registry record
A Study on Patients With Chronic Kidney Disease (CKD) to Assess Treatment Experience and Patterns, Effect of the Treatment, Patient Outcomes and Patient Quality of Life
A clinical trial, sponsored by AstraZeneca.
- Completed
- Registry status
- 1,052
- Enrollment target
NCT04034992 is a clinical trial that has completed, run by AstraZeneca. The registered enrollment target is 1,052 participants.
The verdict
NCT04034992 has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- 1,052 participants
- Enrollment target
Study Summary
DISCOVER CKD is an international observational cohort study in patients with CKD, comprising both prospective and retrospective patient cohorts. The study does not attempt to test any specific a priori hypotheses, is largely descriptive, and utilises data collected only under conditions of routine clinical care.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,052 participants |
| Start Date | 2019-09-11 |
| Est. Completion | 2023-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04034992
The ClinicalTrials.gov registry entry for NCT04034992 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,052 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04034992 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04034992 about?
NCT04034992 is a clinical study titled "A Study on Patients With Chronic Kidney Disease (CKD) to Assess Treatment Experience and Patterns, Effect of the Treatment, Patient Outcomes and Patient Quality of Life". DISCOVER CKD is an international observational cohort study in patients with CKD, comprising both prospective and retrospective patient cohorts. The study does not attempt to test any specific a priori hypotheses, is largely descriptive, and utilises data collected only under conditions of routine c...
What is the current status of trial NCT04034992?
This trial is currently completed. The enrollment target is 1,052 participants. The study started on 2019-09-11. Estimated completion is 2023-06-30.
Who is sponsoring clinical trial NCT04034992?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.